AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback. At an ...
Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...
This title is part of a longer publication history. The full run of this journal will be searched. TITLE HISTORY A title history is the publication history of a journal and includes a listing of the ...
Quand un rhume tourne dans l’école, au bureau, ou dans le métro, on se pose la même question: que peut-on faire, au quotidien, pour tomber moins souvent ma ...
This page includes information for lectures, seminars. Details of undergraduate class teaching will be published on the Timetables web page in mid-September. Teaching begins on Monday, 29 September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback